tiprankstipranks
XORTX Therapeutics Inc (TSE:XRTX)
:XRTX
Canadian Market
XRTX
XORTX Therapeutics Inc
RESEARCH TOOLSreports

XORTX Therapeutics Inc (XRTX) Income Statement

38 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q4 2025), XORTX Therapeutics Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, XORTX Therapeutics Inc's net income was C$-823.32K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -156.66KC$ -160.66K-C$ -75.27KC$ -17.88K
Operating Expenses
C$ 4.39MC$ 5.48MC$ 4.81MC$ 9.86MC$ 2.90M
Depreciation and Amortization
C$ 156.66KC$ 160.66KC$ 188.54KC$ 75.27KC$ 17.88K
EBITDA
C$ -4.39MC$ -4.38M-C$ -9.41M-
Operating Income
C$ -4.55MC$ -5.64M-C$ -12.43M-
Other Income/Expenses
C$ 837.97KC$ 1.10MC$ 1.95MC$ 2.95MC$ 1.25M
Pretax Income
C$ -3.71MC$ -4.54M-C$ -9.49MC$ -1.65M
Net Income
C$ -3.71MC$ -4.54M--C$ -1.65M
Per Share Metrics
Basic EPS
C$ -3.90C$ -7.90C$ -7.20C$ -23.60C$ -6.00
Diluted EPS
C$ -3.90C$ -7.90C$ -7.20C$ -23.60C$ -6.00
Weighted Average Shares Outstanding
 946.92K 575.70K 396.35K 295.98K 218.82K
Weighted Average Shares Outstanding (Diluted)
 946.92K 575.70K 396.35K 295.98K 218.82K
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History